cellgram-spine

AssetCell therapy

Autologous bone marrow-derived mesenchymal stem cell therapy for spinal cord injury repair.

Stage
Phase 2
Modality
Cell therapy
Target
Stem cell maintenance
Indications
1
Trials
128
Developers
1

Indications

1
  • Targets and what it contains2
  • Owner and partners1
  • Trials128
  • Evidence for its targets2
  • Competitors3
  • Aging relevance1
  • Signals6

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 2 sources

Assets